The NHS Eye Care Crisis: A Government Failure Being Handed to Optometry
Over 600,000 people in England are waiting for NHS ophthalmology appointments right now. Patients have gone blind waiting for injections that were never booked. Nearly 100 incidents of severe harm from delayed eye appointments have been logged since 2019. And the government's response is to ask the people staffing the high street — on a sight test fee of £24.13 — to pick up the pieces. Except it has not even formally asked them yet. It has barely mentioned them.

There is a version of this story being told by professional bodies, NHS England and the government that sounds reasonable, even inspiring. Community optometry is ready to step up. The high street has the infrastructure. Shifting care out of the hospital and into the community is good for patients. The 10 Year Health Plan represents a once-in-a-generation opportunity for optometry.
This article is not that version of the story.
This article is about what is actually happening to NHS eye care in the UK, why it is happening, who is paying the price, and whether optometrists should be asking so many harder questions before volunteering to carry a burden that is not of their making, for a plan that has not formally committed to including them.
What the 10 Year Health Plan actually says about optometry. Which is not much.
The NHS 10 Year Health Plan was published on 3 July 2025. It sets out an ambition to shift care from hospital settings into the community — a direction that optometry clearly fits within. The AOP welcomed it as an "essential reset." The College of Optometrists expressed support for its broad principles. The OFNC and the College jointly announced they were "standing by to deliver."
Read those responses carefully. Standing by to deliver is not the same as being asked to deliver. Welcoming broad principles is not the same as having funded, mandatory commitments written into policy.
The College of Optometrists' own briefing on the plan described it as offering "broad direction" while noting that "many important details remain unclear, particularly on implementation and funding." That is careful professional language for: the plan does not actually say how this happens or who pays for it.
The 2023 NHS Long Term Workforce Plan — the document that should have set out how different clinical workforces fit into the NHS's future — omitted specific provision for optometrists entirely. The College described this at the time as "a missed opportunity." That was two years before the 10 Year Health Plan. The pattern of optometry being acknowledged in general terms and absent in operational specifics is not new.
Then came the NHS Neighbourhood Health Framework, published in April 2026, which was supposed to provide the operational detail the 10 Year Plan lacked. The AOP described it plainly as "a huge opportunity missed." The framework defines primary care as GP-led care only. Community pharmacy, dental services and optometry are explicitly not included in the initial priorities. The commitment to optometry within the framework, in the AOP's own words, is "a vague commitment to look at how these can contribute to neighbourhoods in the next few years."
So, to be precise about where optometry actually stands: the 10 Year Health Plan referenced the profession in principle within a broad hospital-to-community ambition—the workforce plan before it omitted optometry entirely. The operational implementation framework that followed has left optometry out of the first wave with no timeline, no funded tariff and no mandatory commissioning requirement. The professional bodies are not celebrating inclusion in a plan. They are campaigning to be included in one that has so far declined to make that commitment in any operational sense.
That is a significantly different position from the one the sector's public communications tend to convey.
What is actually happening to NHS hospital eye services?
While the policy conversation continues, the clinical reality on the ground is deteriorating. Ophthalmology is the busiest outpatient speciality in the NHS — over 8 million appointments a year. And yet the NHS hospital eye service is in a state of sustained, structural decline that predates the pandemic and has accelerated since.
As of early 2026, over 600,000 people in England are waiting for NHS ophthalmology appointments. More than 27,000 of them have been waiting over a year. For most conditions — a cataract blurring central vision, a glaucoma follow-up months overdue — the wait is distressing and damaging. For some conditions, it is catastrophic.
Wet age-related macular degeneration — the most aggressive form of the UK's leading cause of blindness — can cause permanent, irreversible central vision loss within weeks if injections are not administered on time. The National Reporting and Learning System has logged 551 incidents of sight loss linked to delayed NHS appointments since 2019. Ninety-nine of those incidents involved severe harm. One patient lost vision in their left eye after three months had passed between injection appointments that were supposed to be monthly. Nobody booked the next one.
These are not statistics about a system under pressure. These are people who went blind in the queue.
The private cataract problem nobody is talking about loudly enough.
In 2018–19, the private, for-profit sector accounted for 24% of NHS-funded cataract procedures in England. By 2022–23, that figure had reached 55%. By 2024, it was pushing 60%. Over 100 low-cost private eye care clinics, many backed by private equity, have opened across England in the last five years, offering lucrative contracts to NHS staff and bidding aggressively for NHS commissioning contracts on cataract pathways.
Cataract surgery is the most common surgical procedure in the NHS. It is also, relative to other surgical specialities, high-volume and relatively predictable — the kind of procedure that generates reliable income with manageable risk. The private sector saw this, moved in, and took it. NHS hospitals have, on average, lost around 20% of their cataract income as a direct result.
That income does not just pay for cataract surgery. It cross-subsidises the clinically vital but less commercially attractive work — glaucoma monitoring, wet AMD injections, retinal detachment surgery, paediatric ophthalmology — that private sector providers largely do not want and are not commissioned to do. When the profitable work leaves, the funding for everything else goes with it.
A survey of NHS ophthalmology clinical leads found that 67% said the impact of independent sector provision on their department had been negative. 58% of eye units said independent providers were negatively affecting their services. The area most frequently cited as damaged was training — 73% said independent sector expansion had harmed training opportunities.
When 60% of the most common training operations in ophthalmology move out of NHS hospitals, trainee surgeons lose the volume and variety of cases they need. Ophthalmologists in the next decade are being undertrained because the most common training case has been outsourced to facilities whose commercial interests do not include training the next generation of NHS consultants.
A peer-reviewed paper in the journal Eye in 2025 put it plainly: the independent sector has done cataract surgery "at considerable expense, impacting training, less lucrative aspects of ophthalmology, and leaving behind those with the most complex needs." And yet the formal policy response continues to expand the role of independent providers further.
The postcode lottery that twenty years of policy have failed to fix.
Enhanced community eye care services — the MECS and CUES pathways that allow high street optometrists to manage minor eye conditions locally — work. The evidence is not contested. When commissioned consistently, they reduce hospital pressure, improve patient access, and are cost-effective. Parliamentary evidence has cited estimates that full national rollout could free up 2 million NHS appointments annually, including 1.2 million in hospital eye services, generating a net gain of £98 million per year.
They have been available as a commissioning option for years. They are still not nationally commissioned. As of 2025, five ICBs in England were still not commissioning any minor eye conditions service. Whether your local ICB has decided to fund them determines whether your optometrist can help you or can only refer you to a back-of-the-queue list that already has 600,000 people on it.
This is not a resource problem created by patients. It is a commissioning failure created by a system that has repeatedly chosen to leave optometry outside the formal architecture of NHS care, acknowledge its value in strategy documents, and then fail to fund it. The 10 Year Health Plan has thus far not committed to fixing this with the one thing that would actually fix it: mandatory national commissioning with a properly funded tariff.
The question employed optometrists should be asking.
Here is the position that employed optometrists in England are increasingly being invited to occupy. They are expected to upskill. To take on enhanced clinical roles. To manage glaucoma referrals, monitor chronic conditions, triage urgent cases, and prescribe medications. The clinical and educational push for optometrists to work at the top of their scope of practice is, in isolation, a reasonable professional development direction.
But at the same time, the NHS sight test fee is £24.13. A 2.5% increase described by the OFNC as "below inflationary" and "deeply disappointing" after seven months of negotiations. The OFNC made the case for a minimum of £25. NHS England rejected it on grounds of affordability — in a year when the NHS budget grew by billions. Wales and Scotland fund sight tests at significantly higher rates. The question of why England cannot deserve a direct answer, and is not receiving one.
Employed optometrists in NHS Band 6 roles earn from around £32,000. Band 7 from £41,000. The demand for eye care is projected to rise by 40% over the next two decades. The College of Optometrists projects a shortage of nearly 2,000 practitioners by 2030. One in ten NHS optometry posts is already vacant. The profession is being asked to absorb more work, more clinical risk, and more accountability within a framework that has not formally included it in policy priorities, has not committed to funding it adequately, and has a track record of freezing or under-inflating the fees that underpin its economic viability.
Taking on more clinical responsibility under these conditions is not the same as securing better recognition for the profession. It may simply mean doing more for less, within a system that has learned it can rely on professional goodwill to paper over structural failures.
What actually needs to happen.
The problem with NHS hospital eye services is not that there are too few high street optometrists willing to do more. It is that hospital eye services have been hollowed out by chronic underfunding, the private sector's extraction of profitable cataract work, the consequent collapse of training pipelines and cross-subsidy, and years of political indifference to ophthalmology as a speciality. The solution to that problem is not to ask community optometrists to absorb the resulting backlog, particularly before the funding, commissioning infrastructure and formal policy commitment exist to make that absorption sustainable.
The specific things that would actually make a difference are not complicated to state. Mandatory national commissioning of MECS and CUES at a properly funded tariff, so every patient in England can access urgent and enhanced eye care through their local optometrist. A GOS sight test fee that reflects the actual cost of delivering a thorough clinical examination — not £24.13. Genuine accountability for what the private sector's expansion into NHS cataract surgery has done to training and hospital department viability. Sustained investment in the hospital eye service as a public institution that needs protecting, not managing down. Read-write access to patient records for community optometrists to enable shared care. And a national eye health strategy — repeatedly called for over years — that sets out, with legal and financial force, where different parts of the system are responsible for what.
These are not radical demands. They are the minimum conditions under which an integrated community eye care model could plausibly function.
A question worth sitting with.
The professional bodies in optometry are in a difficult position, and their advocacy work is real. Engaging constructively with the 10 Year Plan makes sense as a long-term strategy. Making the case for optometry's role in the future NHS is the right thing to do.
But there is a version of that engagement that looks less like professional advocacy and more like accepting the terms of a bad deal before the deal has even been formally offered. The 10 Year Health Plan mentioned optometry in general terms and offered no operational commitment—the workforce plan before it omitted the profession entirely. The implementation framework that followed has explicitly deferred optometry to a future wave with no date attached.
Patients are losing their sight on NHS waiting lists right now. The private sector is making significant profits from publicly funded procedures used to train the next generation of eye surgeons. The government's operational framework has just confirmed that optometry is not in the first wave of priorities. And the sight test fee is £24.13.
There is a strong argument that the most important thing the profession could do right now is not to volunteer to absorb the consequences of a crisis it did not create, but to make enough noise about who did create it, and what actually fixing it requires, so that the public and their MPs cannot look away.
The eye care crisis in this country is not an optometry problem to solve. It is a government failure to name.
What do you think? We would genuinely like to know. Leave a comment below.
Share
Related Posts
-

The Independent Practice That Used Comedy to Get Noticed
Most independent opticians post a photo of a new frame collection and call it marketing. Little Spectacle Shop in Hex...
-

Eyewear Trends 2026: What Mido Means for Independent Practices
The biggest eyewear trade show in the world just wrapped in Milan. 42,000 buyers, designers, and retailers from 160 c...
-

Digital Test Charts: Worth It for Independent Practices?
A test room with a wall-mounted chart and a chin rest that the patient can't move is not a clinical decision. It's a ...


